Skip Navigation


European Heart Journal Advance Access originally published online on October 13, 2005
European Heart Journal 2005 26(24):2605-2606; doi:10.1093/eurheartj/ehi596
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/24/2605    most recent
ehi596v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lindeberg, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindeberg, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Who wants to be normal?

Staffan Lindeberg*

Department of Clinical Sciences, Lund University, Lund, Sweden

* Corresponding author E-mail address: staffan.lindeberg@med.lu.se

This editorial refers to ‘Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001'{dagger} by Hartz et al., on page 2673

The first 10% of the full text of this article appears below.

Is the average elderly Norwegian at high risk of cardiovascular disease after 60 years of age? Will most of these men and women need health care or even drug treatment in order to lower serum lipids and/or blood pressure? Well, according to the present guidelines of the European Heart Association, this actually seems to be the case.1 Hartz et al.2 show that in Tromsø, Norway, the vast majority of men >60 years, and females >70, have a 10-year risk of fatal cardiovascular disease exceeding 5%, the suggested limit for intervention. We can argue about the exact figures, including the (unpublished) confidence interval of the 5% limit, but the main message is clear: it is normal to be at ‘high’ risk. And what is true for Norway would be true for most other . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001
Ingeborg Hartz, Inger Njølstad, and Anne Elise Eggen
EHJ 2005 26: 2673-2680. [Abstract] [Full Text]